Skip to content

Septerna, Inc. SEPN Research Development Programs And Manufacturing Services — Variable Consideration

Similar metrics at other companies

MoonLake Immunotherapeutics logo
MLTXLicense — Variable consideration amount
$8.1M0.0%
BioCryst Pharmaceuticals logo
BCRXResearch and Development — Contract with customer, transaction price
$20.67M
Innoviva, Inc. logo
INVAResearch And Development Support — Future Potential Milestone Payment
$91M0.0%
MoonLake Immunotherapeutics logo
MLTXLicense — Revenue remaining performance obligation additional variable consideration amount
$344.3M+6.2%
Lantheus Holdings logo
LNTHIn Process Research And Development Included In Liabilities
$1.45M
IDEAYA Biosciences, Inc. logo
IDYAResearch And Development Services — Revenue Remaining Performance Obligation
$155.3M

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept sepn:VariableConsideration.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s research development programs and manufacturing services — variable consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s research development programs and manufacturing services — variable consideration?
Septerna, Inc. (SEPN) reported research development programs and manufacturing services — variable consideration of $10.3M in Q1 2026.
How has Septerna, Inc.'s research development programs and manufacturing services — variable consideration changed year-over-year?
Septerna, Inc.'s research development programs and manufacturing services — variable consideration increased by 121.5% year-over-year, from $4.65M to $10.3M.
What does research development programs and manufacturing services — variable consideration mean?
This metric captures the portion of transaction price that is contingent upon the occurrence or non-occurrence of future events, such as the achievement of specific clinical, regulatory, or commercial milestones. It reflects the potential future value of research and development partnerships beyond the initial upfront payments. Monitoring this metric provides insight into the long-term revenue potential and the risk-adjusted success probability of the company's pipeline development programs.